iVNS significantly improved motor performance and NE c‐FOS activity in LC, reduced TNF‐ɑ, IL‐1β, Iba‐1, GFAP, and enhanced DA neuron survival, further supporting its potential as a neuroprotective therapy for PD.27 Here, GFAP is linked to Parkinson disease.